[HTML] frontiersin.org

[HTML][HTML] Growth hormone cotreatment for low-prognosis patients according to the POSEIDON criteria

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …
被引用次数：10 相关文章
[HTML] nih.gov

[HTML][HTML] Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - ncbi.nlm.nih.gov
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in endocrinology, 2021 - pubmed.ncbi.nlm.nih.gov
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - europepmc.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …